Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-22

Clinical Trial Update: Allopurinol Maintenance Study for Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating maintenance allopurinol for bipolar disorder has been terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Bipolar Disorder, Mania | Phase 4 | Status: TERMINATED | Results posted: 2018-02-22